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INTRODUCTION 
 
Rhinitis,sinusitis and asthma co-exist often. The role played by sinus disease 
in an  asthmatic patient is partially understood always because of the existing deficits 
in  classification of the disease and etiopathogenesis of airway disease. By the                    
upcoming clinical   studies in sinus inflammation and airway remodeling a link            
between the upper airway and lower airway has been established as “united airway 
disease”1. This explains the  relationship between sinus disease and asthma(allergic 
and non-allergic).   
This  relationship can be demonstrated in terms of epidemiological basis and 
improvement in signs and symptoms of an asthmatic patient by treating sinusitis either 
medically or  by surgical methods.  
This study focuses on the impact occurring in an asthmatic patient in                        
mucociliary clearance, pathogenesis and chronicity of the disease by treating                   
rhinosinusitis. 
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AIMS AND OBJECTIVE 
 
 
1.  To study the relationship between sinusitis and asthma. 
2. To study about benefits of medical and surgical treatment of sinusitis in         
asthma patients. 
3. To study the improvement in lung function test by treating sinusitis in asthma  
patients. 
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REVIEW  OF  LITERATURE 
 
The concept of  “united  airways disease”  putforths  the relationship between 
upper and lower respiratory disease.  The link between the two has been reviewed and 
are cited  below. 
In 1992, Dr. Raymond G.Salvin115 and his team  studied the mechansims relating 
the upper and lower airways as eosinophil acting as effector cell, inflammatory         
mediators and vagal reflex. He suggested that prospective studies on effect of medical 
and surgical therapy need to be done . 
In a rabbit model sterile maxillary sinusitis was induced by chemotactic            
complement fragment  C5a  produced a significant airway responsiveness to histamine 
in contrast to rabbit  injected with a saline diluent which had nil inflammation. The 
mechanism hence putforth was postnasal dripping of cells or cell products in lower 
airway. This was     studied by Dr.Susan.M.Brugman in the year 1993122 . 
 Department of  Head and neck surgery of University of Missouri-Columbia116    
in 1994 conducted a study  on twenty asthmatic patients  who underwent functional 
endoscopic sinus surgery . A concomitant  reduction in usage of inhaler and steroids 
was noticed in patients who underwent  FESS with improvement in  peak expiratory 
flow rate too.  
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Senior  and Kennedy  in the year 1996 ,  of  University of Pennsylvania 117              
described the pathophysiologic links between sinusitis and asthma and  outcome in 
managing the  asthmatic patient with  sinusitis. 
In 1999,I.Annesi –Maseno of  France118, published  an article on epidemiological 
evidence of the occurrence of rhinitis and sinusitis in asthmatics. It provided the             
information on the prevalence of association and factors which impact on this               
relationship. Though no genetic coherence between the two was found, environmental 
factors association in pathogenesis of  both the disease was correlated by them. 
University of Virginia119  health system in the year 2002  studied the relationship 
between sinusitis and asthma. 
The histopathological characteristics of chronic sinusitis with bronchial asthma  
showed marked chronic inflammatory reaction , and that  eosinophil infiltration  plays 
as a significant role  in inflammatory reaction in both sinusitis and asthma as studied 
by    Hun-Jong Dhong in 2004. 
The impact of sinusitis on lower airway disease was studied by 
Dr.Annie.E.Dixon and  Dr.David in year 2006120  and found out that  exacerbation of 
the lower airway disease was more in patients with sinusitis. 
  In 2009121 , Vermont Lung Centre  published  that sinusitis is the commonest        
comorbidity associated with asthma. The sequence of disease and inflammatory  
pathways suggest that there is a common disease process for both sinusitis and              
asthma. 
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The Global  Allergy and Asthma network of  Excellence conducted a survey in              
representative sample of adults living in Europe  to assess the presence of asthma and  
sinusits in the year 2011123 .  
The united allergic airway that connects chronic rhinitis and asthma which seems 
to be a separate disease are  actually a common atopic entity as proposed by  Feng and 
Charles in the year 2012124 . 
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HISTORY 
In ancient Greece,Galenus 2 was the first physician to recognize the link between 
the nose and lung. 
There is evidence that ancient greeks studied about “asthma” under the guidance 
of   Hippocrates in the 4th century B.C..He also believed that sinuses drained mucus 
from brain to nasal cavity 3 . The word asthma itself  is greek in origin mentioned  in 
the  ancient text book of Iliad. 
In 8th century B.C. Homer was the first to describe the term “thorax”4. 
Leonardo da Vinci in 15th century was the first artist to draw the anatomical              
appearance of  maxillary and frontal sinuses5.  
During 16th century a Belgian physician by name Jean Baptiste Van Helmont 
wrote that asthma originated in the pipes of lungs. Andreas Vesalius6 Belgian                 
anatomist described   maxillary and frontal sinuses as aerated cavities. 
In 17th century Bernado Ramazzini an Italian physician found out the relation  
between asthma and organic dust. 
In 1873, Charles Blackley, “Father of allergology”  described nasal and               
bronchial symptoms  after exposure to pollen grains. 
In the year of 1919, Sluder  proposed the sinopulmonary  reflex. 
In  1928, Kratchmer  French physiologist  related the link between nasal                 
stimulation and bronchial hyper responsivness. 
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ANATOMY OF THE AIRWAY 
 
EMBRYOLOGY OF NOSE AND PARANASAL SINUSES 
FOURTH WEEK OF INTRAUTERINE LIFE 
The face develops from facial prominences7 around the primitive stomodeum. 
These  facial prominences are neural crest derived mesenchyme of the first pharyngeal 
arch.Lateral to the stomodeum appears the maxillary prominences8 and caudal to it the 
mandibular prominences9. The upper border of stomodeum is formed by the                     
frontonasal prominence10.  On either side of the frontonasal prominence surface              
ectoderm thicken to form the nasal placodes11.  
 
FIFTH WEEK OF INTRAUTERINE LIFE 
The nasal placodes invaginate to form  nasal pits. The nasal pits are surrounded 
by sheet of tissue known as nasal prominences. The outer end of the nasal prominence 
is lateral nasal prominence12 whereas the inner end is known as medial nasal                
prominence13. 
 
SIXTH WEEK OF INTRAUTERINE LIFE 
The maxillary prominences enlarge in size as a result of which medial nasal 
prominences compress in the midline.The medial nasal process fuse in midline to 
form intermaxillary process18. The intermaxillary process forms the bridge of nose  
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First ethmoturbinal ridge regress,ascending portion forms agger nasi22, descending       
portion forms uncinate  process 23. The ascending fold is known as ramus ascendens 
and the descending fold ramus descendens by Stammberger46. 
Second ethmoturbinal ridge  gives rises to middle turbinate24. 
The superior turbinate 25 originates from the third ethmoturbinal ridge. 
The fouth and fifth ridge fuse to form supreme turbinate26. 
While all the above mentioned ridges are ethmoidal in origin, the maxilloturbinal                
inferior to the ethmoturbinals gives rise to inferior turbinate27. The nasal meati arise 
from the    furrows between the ethmoturbinal ridges. The first furrow  or primary       
furrow’s  ascending  superior part forms  frontal recess28 and its descending anterior 
part forms the ethmoidal infundibulum,hiatus semilunaris and middle meatus29. The                 
second furrow forms superior meatus30 while the supreme meatus arises from third 
furrow31. The ethmoturbinals cross the ethmoid complex to attach to lamina 
papraceyae and skull base. 
 
DEVELOPMENT OF PARANASAL SINUSES 
Maxillary sinus develops as a bud from the inferior aspect of  ethmoid infundibulum32. 
Frontal sinus33 development is varied. It may arise from  (1) Frontal recess,   
(2) anterior ethmoid cell (3) anterosupero aspect of  ethmoid infundibulum. 
Sphenoid sinus develops around third or fourth month of  fetal  life from the posterior 
portion of cartilaginous nasal capsule invagination  known as cartilaginous cupolar      
recess35. In later months the cartilage ossify and referred as ossiculum of  Bertini36. 
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The ossiculum of Bertini gets resorbed and attaches to sphenoid bone in second or 
third year of life. 
 The secondary lateral nasal wall evagination gives rise to ethmoid  bulla, supra bullar 
and retrobullar recess34 above and behind to the bulla  to constitue the ethmoid sinus 
or ethmoid complex.  
Paranasal sinus Embryological  
appearance Postnatal  Growth spurt 
Ethmoid Begins at third 
month 
Present at 
birth 
First spurt between 1 to 4 
yrs and second between 4 
to 8 yrs 
Maxillary 65
th
 day of gesta-
tion 
Present at 
birth 
First between birth and 3yrs 
second between 7 and 12 
yrs 
Frontal Begins at fourth 
month 
Detected at 7 
to 12 yrs  Adult size by 20yrs 
Sphenoid Begins at third 
month 
Detected at 3 
to 4yrs 
At 7 yrs starts extending 
posteriorly towards sella 
tursica 
 
ANATOMY OF LATERAL NASAL WALL 
The lateral nasal wall is characterized by ridges and mounds to simplify under-
standing they are better referred to as lamella based on embryological precusors37. 
The first lamella is uncinate process. The second lamella is ethmoid bulla and 
the third one is basal lamella. The fourth one is superior turbinate. The basal lamella 
or middle turbinate is significant in pattern of drainage of sinuses dividing them into 
anterior ethmoid and posterior ethmoid. The sphenoethmoidal recess is located just 
above,   posterior and medial to superior turbinate38. 
The paranasal sinuses can be divided into anterior group of sinuses and posterior 
group39. The frontal sinus, maxillary sinus and anterior ethmoid form anterior sinus 
group while posterior ethmoids and sphenoid sinus constitute the posterior group.  
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The anterior group opens into middle meatus while the posterior ethmoid drain 
into superior meatus and sphenoid into spheno ethmoid recess40.  
The ethmoid air cells are divided into intramural and extramural cells 48 .  The  
intramural cells are further divided into small numerous anterior ethmoid cells and 
large few   posterior ethmoid cells49.  Based on location of ostia of the cells various 
classification  been proposed as given below and the most accepted nomenclature is 
Ritter’s  classification50. 
 
RITTER’S CLASSIFICATION 
ANTERIOR ETHMOID CELLS POSTERIOR ETHMOID CELL 
Frontal recess 
Infundibular  
Bullar  
Conchal 
Extramural cell – agger nasi 
Intramural 
Extramural  
 
As mentioned above dividing the sinuses into anterior group and posterior group          
according to drainage pattern the following discussion is done. 
 
ANTERIOR GROUP OF SINUSES 
The anterior group of sinuses drain into the osteomeatal complex located in the 
middle meatus. 
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THE OSTEOMEATAL UNIT OF NAUMANN 
The osteomeatal  unit refers to various structure draining into middle meatus41. 
The  components of osteomeatal unit are 
Air cells of anterior ethmoid and their ostia 
Frontal sinus ostia  
Maxillary sinus ostia 
Uncinate process 
Ethmoidal infundibulum 
The advent of endoscope had made the viewing of osteomeatal complex easier. 
To start with osteomeatal complex view we have to surpass the agger nasi cell  which 
is the first anterior ethmoidal cell . 
 
AGGER NASI 
It has its origin from superior aspect of infundibulum or frontal recess42. It is  
Anteriorly bounded by frontal process of maxilla 
Superiorly by frontal recess 
Anterolaterally by nasal bones 
Inferomedially by uncinate process 
Inferolaterally by lacrimal bone43 
Agger nasi plays a significant role in frontal sinusitis pathophysiology as it forms 
the floor of the frontal sinus. 
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CONSTIUENTS OF OSTEOMEATAL UNIT 
UNCINATE PROCESS 
The uncinate is hook shaped and sagitally oriented.  Its attachments44 are 
Anterosuperiorly to ethmoidal crest of maxilla 
Posteroinferiorly to ethmoidal process of inferior turbinate 
Posterosuperiorly to lamina perpendicularis of palatine bone 
Superiorly to lamina paprayacea,middle turbinate or cribriform plate. The                
uncinate may attach to any of the above stuctures superiorly as observed by                
Stammberger45. Depending on its attachment frontal recess drainage differs as                
suggested by Van Alyea 61.When  it attaches to lamina papracea, ethmoidal                     
infundibulum ends blindly in terminal recess46 and frontal recess opens directly into 
middle meatus. If it attaches to skull base or middle turbinate the frontal recess opens 
into ethmoidal infundibulum. Extensive pneumatisation of the uncinate can result in 
obstruction to the drainage of infundibulum47.   The posterior free rim forms the                   
anteromedial boundary of ethmoidal infundibulum.  
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ETHMOID BULLA 
It was named by Zuckerkandl53it is attached laterally to the lamina papyrcea.                 
Relationships of bulla54 
Anteroinferiorly it is separated from the infundibulum by uncinate process.        
Superiorly from the fovea ethmoidalis by supra bullar recess and posteriorly                  
separating it from the basal lamella by retrobullar recess. Medially it is separated from 
the middle turbinate by middle meatus and the lumen is known as conchal sinus. The 
hiatus semilunaris inferior lies between bulla and free edge of uncinate to lead into  
infundibulum. 
 
ETHMOID INFUNDIBULUM 
The term infundibulum was first coined by Baron Alexis de Boyer51. It is a 
three  dimensional funnel shaped passage52 in which the secretions of anterior                  
ethmoids, maxillary sinus and sometimes frontal sinus  to drain into middle meatus 
occur. 
Its boundaries are 
Medially- uncinate process 
Laterally- lamina papyracea 
Anterosuperiorly-frontal process of maxilla,frontal recess and frontal sinus ostia 
Superolaterally- lacrimal bone 
Posteriorly-anterior border of bulla 
Posteroinferiorly- maxillary sinus ostia 
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HIATUS SEMILUNARIS SUPERIOR OF GRUNWALD 
It is a two dimensional passage between posterior wall of bulla and basal                   
lamella of  middle turbinate to establish a communication between the middle meatus 
and lateral  sinus. 
 
LATREAL SINUS OR SINUS LATERALIS 
It constitutes the supra bullar recess and retro bullar recess. The suprabullar              
recess lies between ethmoid bulla inferiorly and ethmoid fovea superiorly55. The  
retrobullar recess is located between the ethmoid bulla anteriorly and basal lamella 
posteriorly56. 
 
MAXILLARY SINUS 
It is largest of all the sinus and pyramid in shape. Its roof is formed by orbital 
floor, floor by the alveolar process of maxilla and hard palate. Its bound medially by 
uncinate, fontanelles and inferior turbinate, laterally by zygomatic process. Posteriorly 
it is  separated from the infratemporal fossa and pterygopalatine fossa by a thin plate 
of bone and anteriorly by facial surface of maxilla57. 
The ostia is located in the posteroinferior end of infundibulum. The fontanelles 
are devoid of bone and named as anterior and  posterior in reference to its position 
with uncinate. The fontanelles are usually made up of nasal mucosa and maxillary   
sinus mucosa58. The natural ostia is present in the posterior fontanelle usually. 
 
 
  
17 
 
FRONTAL SINUS AND RECESS 
The frontal sinus drains into middle meatus via frontal recess. The frontal                
recess is an hour glass shaped lumen59. The frontal recess60 is bounded  
Laterally- lamina papyracea 
Medially- middle turbinate 
Anteriorly-posterosuperior wall of agger nasi 
Posteriorly- anterior wall of bulla 
Depending on the attachment of uncinate the drainage of sinus differs as             
mentioned  earlier . 
Van Alyea 62 classified accessory cells in frontal region as  
1.Frontal cells- those cells which occupy frontal recess area 
2.Invading cells-Supraorbital cells and intersinus septal cells which manage to 
invade the frontal sinus. 
Bent’s 63 classification of accessory frontal cells based on location 
1.Type I- single frontal cell above agger nasi cell 
2. Type II- tier of two or more cells above agger nasi 
3. Type III – a single frontal cell which is massive and pneumatize superiorly 
into frontal sinus 
4.TypeIV- the cell is entirely within frontal sinus   
The anatomy of middle and inferior turbinate has to be discussed here as their 
position and attachments influence the drainage of anterior group of sinus. 
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MIDDLE TURBINATE 
The middle turbinate is boomerang shaped charecterised by conchal head,                 
conchal neck and conchal sinus64 . Attachments of the middle turbinate are  
Anteriorly- crista ethmoidalis of maxillary bone and agger nasi65 
Posteriorly- ethmoidal crest of perpendicular plate of palatine bone. 
The middle turbinate can be divided into three parts  
PART LOCATION PLANE ATTACHMENT 
First Anterior  Sagittal  Skull base  
Second  Middle or basal Frontal  Lamina papyracea 
Third  Posterior  Horizontal  Perpendicular plate 
of palatine bone 
 
The basal lamella is of utmost importance as it divides the sinus into anterior ethmoid 
and posterior ethmoid. The boundaries66  are 
Superiorly- fovea ethmoidalis 
Laterally –lamina papyracea 
Inferiorly – the attachment of third part of middle turbinate to basal lamella 
Medially- – the attachment of first part of middle turbinate to basal lamella. 
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Medially- superior meatus and  turbinate 
Superiorly – fovea ethmoidalis separating it from anterior cranial fossa 
Inferiorly – posterior part of middle turbinate 
 
The posterior ethmoids 70  are important because of their close relationship with 
orbit and sphenoid sinus. The medial rectus is near to posterior ethmoids than its             
anterior counterpart. The posterior most ethmoid cell in relation with optic nerve and 
internal carotid   artery  is known as “Onodi cell” or sphenoethmoid cell . the posterior 
ethmoidal artery runs in the roof of sinus and more prone for injury. 
 
SPHENOID SINUS 
The sphenoid sinus is located in the centre of the skull. Its relationships71  are as 
follows 
Superiorly- anterior cranial fossa 
Inferiorly – nasopharynx 
Anterior – sphenoethmoid recess, superior turbinate and posterior ethmoids 
Posterior- basi sphenoid, sella and posterior cranial fossa 
Medially – sphenoid septum 
Laterally – middle cranial fossa and  cavernous sinus 
Based on pneumatisation sphenoid sinus classified into conchal, presellar and 
sellar72.  The sphenoid sinus ostium located in inferomedial edge of superior                 
turbinate73 .  
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Hypoplastic / aplastic maxillary sinus 
Aerated crista galli91  
 
VASCULATURE OF NOSE 
ARTERIAL SUPPLY76  
ARTERY  BRANCH OF  AREA SUPPLIED 
Anterior and posterior 
 ethmoid artery Ophthalmic artery 
Roof of nose, upper lateral 
wall of septum, ethmoid 
and frontal sinuses 
Sphenopalatine  Maxillary artery Superior and middle mea-
tus and septum 
Greater palatine Maxillary artery 
Posterior part of lateral 
 nasal wall and anteroinfe-
rior part of septum 
Superior labial  Facial artery Vestibule of nose 
Infra orbital,  
posterosuperior alveolar 
and anterosuperior alveolar 
Maxillary artery Mucous membrane of  
maxillary sinus 
Pharyngeal branch of 
 maxillary artery Maxillary artery Sphenoid sinus 
Branches from internal  
carotid artery  Sphenoid sinus 
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TYPE OF CELL FUNCTION 
Goblet cell Secrete mucous blanket which protects 
nose  
Columnar cell Promote exchange across the epithelium 
Basal cell Provide adhesion between cells 
  
The basement membrane separated from epithelium by lamina propria. The 
submucosa is invaded by the nerves , blood vessels and glands. There are three               
submucus glands as follows anterior serous glands and seromucinous glands                      
responsible for nasal mucosa moisturization, while bowman’s glands helps in                   
olfaction79 . 
 
DEVELOPMENT OF LUNGS 
In a four week old embryo lung bud appears as outpouching from the ventral 
wall of foregut80 .  As it expands the tracheoesophageal ridges appear dividing the 
foregut into dorsal portion  esophagus and ventral trachea and lung buds.  
At fifth week , lung buds forms trachea and two lateral outpouchings called 
bronchial buds81 enlarging to form right and left bronchi. The right bronchi forms 
three secondary bronchi and the  left forms two secondary bronchi. As a result three 
lobes in right lung and two lobes on the left side occur.  
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RIGHT LUNG LEFT LUNG 
Superior lobe- anterior, posterior,apical Superior lobe- apical, posterior, anterior, 
superior lingular, inferior lingular 
Middle lobe – lateral, medial Inferior lobe- apical, medial basal,lateral basal, anterior basal,posterior basal 
Inferior lobe- superior,medial basal,lateral 
basal,anterior basal and posterior basal  
 
BLOOD SUPPLY OF LUNGS 
The bronchi, connective tissue and visceral pleura supplied by bronchial arteries 
branch of descending aorta. The bronchial veins drain into azygos and hemiazygos 
vein87   . 
NERVE SUPPLY OF LUNG 
The root of lung has pulmonary plexus which is composed of afferent and efferent       
autonomic nerves88 . 
HISTOLOGY OF LUNGS89 
The epithelia of trachea and principal bronchi is pseudostratified ciliated               
columnar epithelium. It consists of goblet cells and basal cells.  The subepithelial  
connective tissue has elastic fibres, serous glands to keep epithelium moist and             
mucous glands. 
The bronchi as it becomes smaller is lined by simple ciliated columnar, then 
non-ciliated columnar and finally simple cuboidal. Six type of epithelial cells has been 
demonstrated in conducting airways such as ciliated columnar, goblet,clara ,                      
basal, neuroendocrine  and brush cells. In respiratory airways type I and type II  
pneumocytes citied90 . 
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PHYSIOLOGY OF AIRWAYS 
The nose and sinuses is considered as one organ though phylogenitcally nose is organ 
of olfaction and sinuses help in growth and structure of  facial bones. 
The functions of nose and sinuses are as follows102  
1. Respiration 
2. Humidification 
3. Filtration 
4. Nasal resistance 
5. Heat exchange 
6. Mucociliary clearance 
7. Nasal reflexes 
8. Voice modification 
9. Protection of lower airway 
10. Olfaction   
 
Mucociliary transport or clearance  is of utmost importance because it is responsible 
for drainage ,ventilation , humidity,filtration and olfaction purpose of sinuses and 
nose. The mucus in nose is secreted by the goblet cells and seromucinous glands. 
About 600 to 700ml of mucus is produced everyday. The two sinuses where goblet 
cells are large in number are ethmoid and maxillary sinuses. The mucus layer changes 
every 10 minutes in these sinuses. The genes coding mucin proteins are MUC5AC, 
MUC5B ,MUC2 and  sixteen other genomes has been coded95 . 
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COMPOSITION OF MUCUS 
95%water 
3% mucin 
2% other particles 
By electrophoresis proteins in mucus found out to be immunogloublins, glycoproteins 
(sialomucins, fucomucins, sulphomucins) help to trap foreign particles,                             
albumin, prealbumin and lysozyme,lactoferrin, complement,macroglobulin, C-reactive 
protein and ions92  . The nasal cilia is of size 7 micrometer long and 0.3 micrometer 
thick. Each nasal cell may have 200 to 300 cilia with 150 microvilli. Cilia is made up 
of nine pairs of microtubules around a central pair. There is three types of bond93   in it 
 1.Nexin which are elastic doublets and act as small bridges  
2. Dynein arms which coordinate the doublets to slide in synchyronisation  
3. Spokes which keep the cilia from breaking apart  
Understanding the structure of cilia is important to know the phases of mucociliary 
transport namely “sol” and “gel”. In sol phase or inner serous layer of mucus film 
when the cilia beat and transport the viscous outer layer or gel phase over it. The cilia 
beat 10 to 15 times per second. The cilia move individually in synchronized and               
metachronized pattern94 . The biphasic motion of cilia has an effective phase and slow             
recovery phase. 
FACTORS AFFECTING CILIARY MOTILITY96  
Temperature below 32 c and more than 40 c 
Bronchitis and asthma where mucus becomes viscous, mucus becomes alkaline unlike 
in infections where it becomes acidic. 
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Dehydration , nasal decongestants and diuretics stops cilia. 
Deviated nasal septum causes desiccation of cilia. 
Viral infections cause clumping of cilia. 
Mycoplasma infection cause ciliary disorganization and results in ineffective motility. 
Pseudomonas growth causes detachment of ciliated cells. 
Allergens cause disruption of basal bodies. 
Smoking results in reduction of ciliary beat frequency. 
VitaminA overdosage cause squamous metaplasia. 
Congenital conditions affecting ciliary motility are Kartagener’s syndrome and                 
immotile cilia syndrome. 
  
TRANSPORTATION PATTERN IN SINUSES 
The transport within sinuses are genetically programmed in a pattern that directs the 
flow of mucus in a predetermined manner from the interior of sinus to natural ostia of 
sinus and from there to nose. Any disruption in this pattern hinders the ventilation and 
drainage of sinuses resulting in rhinosinusitis. 
 
MAXILLARY SINUS TRANSPORT97  
The secretions are transported from the floor of  the sinus in stellate pattern. It is           
transported along the anterior,medial,posterior, lateral wall and roof of the sinus to             
converge along the natural ostia. 
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FRONTAL SINUS TRANSPORT98  
It is the only sinus where an active inwardly directed transportation of mucus. Mucus 
is transported along the interfrontal septum, laterally along roof and medially through 
the floor , inferior portions of the posterior and anterior wall of sinus from there  the            
secretion exits via lateral aspect of ostia. Mucus is not clear in one round it                
accumulates in a whorl like pattern. Secretions from frontal and maxillary sinus 
merge and drain   finally into nasopharynx. 
 
ETHMOID SINUS99  
Depending on the location of ostia mucus transportation in ethmoid sinus varies, 
If in floor of ethmoid cell ostia is present – secretion is towards the ostia. 
If ostia is located higher up as in bulla ethmoidalis- spiral pattern seen. 
Presence of ground lamella divide the secretion transport between anterior ethmoids 
and posterior ethmoids .  Anterior ethmoids drain anteroinferior to ground lamella 
whereas the posterior ethmoids drain posterosuperiorly. 
 
SPHENOID SINUS100  
There is a spiral pattern towards the ostia. 
Drainage of sinuses into nasopharynx occur eventually where two routes have been           
observed. 
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The frontal sinus, maxillary and anterior ethmoids drain anteroinferior to eustachian 
tube orifice while posterior ethmoids and sphenoid sinus drain posterosuperior to             
Eustachian tube orifice101 .  
By way of filtration, humdification and immune propertis of nasal mucus it protects 
the lower airways. 
 
IMMUNE FUNCTIONS OF NOSE102  
DEFENSE MECHANSIMS HUMORAL CELLULAR 
Mechanical Mucus  Ciliary epithelium 
Specific immune response Complement,lysosome and 
lactoferrin 
 
Granulocytes, macrophages 
Non-specific immune re-
sponse 
Immunoglobulin  Lymphocytes  
 
INNATE IMMUNITY 
The nasal epithelium is a weak barrier against infections unlike mucus which is a              
protective barrier against invasion of micro organsims and toxic substances.                    
Lysozyme has anti bacterial and bacteriostatic properties against gram positive              
bacteria, in case of gram negative bacteria it exerts lytic action by antibody activated 
complement system. Lactoferrin’s microbicidal action against organism dependent on 
iron for metabolism   eg: Candida Albicans. Secretory leukoprotease inhibitor,  uric 
acid, peroxidase, amino peptidase,phospholipaseA2 and defensins present in nasal  
mucus play major role in innate immune mechanism. Special mention of nitric oxide  
present in nose and sinuses is a must in defense mechanism of nose .  
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If the above mechanism fail non specific immune response is established. Release of       
bioactive and chemotactic factors like interleukins,cytokines and chemokines                  
responsible for inflammation is observed in this type of response. 
 
ADAPTIVE IMMUNITY 
Humoral immunity combat infection and IgE mediated responses by mucosa 
associated lymphoid tissue(MALT) present in nasopharynx, bronchi and gastro               
intestinal tract. 
 
NASAL REFLEXES103  
Nasal reflexes help to understand the central nervous system afferents and                
efferents mechanisms that cause local mucosal and systemic changes.  
 
FUNCTIONS OF PARANASAL SINUSES104 
   The function of sinuses are as follows 
1.Vocal resonance 
2. Air conditioning 
3.Reduction of skull weight 
4.Mechanical rigidity 
5.Heat insulation. 
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PULMONARY PHYSIOLOGY105  
The lung’s primary function is to facilitate exchange of gas , right from inspired gas to 
removal of carbon dioxide necessary of acid base balance. The inspired gas from               
upper airway reaches the terminal bronchiole or conducting zones through transition 
zone and respiratory zone. Thus pulmonary physiology deals with breathing                      
mechanics, ventilation –perfusion interchange and gaseous diffusion. 
 
To understand the above mechanics lung volumes and lung capacities should be                        
discussed. The four standard lung volumes106  are 
 
LUNG VOLUMES  
Tidal volume- volume of gas exchanged by quiet respiration it is 500ml. 
Expiratory reserve volume- extra volume of air which is expired forcefully and                 
accounts to 1100ml. 
Inspiratory reserve volume- extra volume of air which can be inspired forcefully it 
is about 3000ml.  
Residual  volume- amount of air remaining in lungs after forceful expiration is 
1200ml.  
 
LUNG CAPACITIES 
Functional residual capacity- amount of gas remaining in lungs after normal 
expiration and is about 2300ml.it is determined by elastic recoil pressure of the lung 
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and outwardly directed chest wall recoil pressure(total lung capacity – inspiratory               
capacity). 
Total lung capacity – volume of gas contained in lung after a maximal inspiration              
(vital capacity + residual volume). It is about 5800ml. 
Inspiratory capacity  is sum of tidal volume and inspiratory reserve volume. It is 
about 3500ml. 
Vital capacity is sum of inspiratory reserve volume, residual volume and expiratory 
reserve  volume.  
All the above mentioned volumes and capacities are measured by spirometer as 
shown below in the diagram 
 
 
FLOW-VOLUME LOOP 107 
The mechanical properties of lung is measured by flow-volume loops. 
The flow rate is plotted against change in lung volume over time.The upper limb of 
the flow volume loop represent forced expiratory flow rate and the peak of it signifies 
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the peak expiratory flow rate(PEFR). PEFR is 8litres per second and occurs at 90% of 
vital capacity. 
In restrictive lung disease there is reduction in  PEFR whereas in obstructive lung   
disease miniature pattern of a normal curve with symmetric reduction in lung volume 
is noted. 
 
NORMAL FLOW-VOLUME LOOP 
 
 
 
RESTRICTIVE LUNG DISEASE
 
Exhaled volume(L) 
Expiration  
Inspiration  
Flow (L/s) 
Time (Second) Volume(litre) 
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OBSTRUCTIVE LUNG DISEASE
 
MEASUREMENT OF VENTILATION 108 
RESTING VENTILATION 
The resting ventilation is calculated by measuring minute ventilation. 
Minute ventilation is the volume of gas exhaled per minute. In turn estimated by               
multiplying tidal volume and respiratory rate per minute. 
Minute ventilation  = tidal volume×respiratory rate/minute(500X12= 6litres/min). 
DEAD SPACE VENTILATION 
Some of the air a person breathes never reaches the gas exchange areas but also fills              
respiratory passages where gas exchange doesn’t occur as in nose,pharynx and                
trachea. This is called as  anatomical dead space. When it includes alveolar dead 
space also it is called as physiological dead space. 
It accounts to about 150ml and 66ml of it is contributed by extrathoracic pharynx and 
mouth. 
By tracheostomy , anatomical dead space is decreased by 60%.Expired minute                 
ventilation measures the dead space ventilation.  
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Expired minute ventilation = alveolar ventilation+volume of gas exchanged between 
blood and alveoli+ volume of gas  wasted ventilating dead space. 
COMPLIANCE OF LUNG109  
Lung compliance is the change in lung volume observed per unit change in pressure           
gradient between the intraplueral space and alveoli. A static pressure- volume  curve 
of the lung is marked by interrupting expiratory or inspiratory maneuver using a 
esophageal balloon tipped catheter present in mid esophagus. The midcurve slope of 
pressure-volume curve represents static compliance. 
The curve is shifted upward and to left in cases of emphysema and old age where  
static compliance is increased.  
It is shifted downward and to right in cases of interstitial lung disease,pneumonia, 
adult respiratory distress syndrome and cardiogenic pulmonary edema. 
 
Normal static compliance curve 
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PATHOPHYSIOLOGY  OF SINUSITIS 110  
The effective functioning of paranasal sinuses require  
Patent osteomeatal complex 
Adequate mucociliary clearance 
Normal mucus production and consistency 
Anatomic or acquired obstruction of the ostia is primary factor in intiation of sinusitis. 
Obstruction of ostia could be caused by local or systemic factors. Local factors like          
septal deviation, polyps, concha bullosa  while systemic factors like bacterial or viral               
infections cause mucosal edema resulting in ostia obstruction. 
Mucociliary clearance is interrupted by intrinsic and extrinsic and factors. 
Intrinsic factors include ciliary dyskinesia ,alteration in local nitric oxide production 
and cystic fibrosis which alters the mucus consistency. Extrinsic factors like exposure 
to  tobacco smoke, infection with viral upper respiratory pathogens. 
Viral infections induce production of cytokines eliciting cellular inflammation thereby 
increasing vascular permeability  as a result edema and ciliary dysfunction. 
In inflammatory conditions nitric oxide production is altered leading to decreased           
antiviral and bacteriostatic protection of the mucus and favouring bacterial                   
colonization and infection. 
 
DEFENSE MECHANISMS IN SINUSITIS111  
Humoral immunity carried out by B-lymphocytes mediated by IgA antibodies in                
detecting and removal of  microbial agent by  opsonization. 
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Cell mediated immunity by T-lymphocytes,macrophages and defensin cytokines.         
Defensins present in mucus binds to microbial agent causing membranr disruption,        
internalization of defensins and cell death eventually. Interruption in any of the above 
factors lead to sinusitis. 
 
                                               
Decreased OMC patency,  
decreased pO2 
mucus stasis 
Increased bacte-
rial growth inflammation 
Decreased mucociliary 
clearance  
Loss of ciliary function 
Ciliary death 
Increased mucus viscosity 
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The classification of  sinusitis is based on duration of symptoms and signs suggested 
by 1996 AA0-HNS Task Force Criteria is as follows 
Major factors Minor factors 
Facial pain/pressure 
Facial congestion/fullness 
Nasal obstruction/blockage 
Nasal discharge/purulence/discolored 
postnasal discharge 
Hyposmia/anosmia 
Purulence in nasal cavity on examination 
Fever  
Headache 
Fatigue 
Halitosis 
Dental pain 
Cough 
Ear pain/pressure/fullness 
 
 
 
Classification Duration History 
Acute < 4 weeks >2 major factors, 
1 major factor and 2 minor 
factors or nasal purelence 
on examination 
Subacute  4-12 weeks >2 major factors, 
1 major factor and 2 minor 
factors 
Recurrent acute >4 episode per year, with 
each episode lasting 7 to 10 
days with absence of signs 
and symptoms of chronic 
sinusitis  
>2 major factors, 
1 major factor and 2 minor 
factors 
Chronic  >12 weeks >2 major factors, 
1 major factor and 2 minor 
factors 
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PATHOPHYSIOLOGY OF ASTHMA112  
Asthma is characterized by hyperreactive airways, leading to episodic , reversible          
bronchoconstriction,owing to increased responsiveness of the tracheobronchial tree to 
various stimuli. 
The airflow obstruction of asthma is due to bronchial smooth muscle contraction,  
mucosal edema and thick mucus secretion.small bronchi and bronchioles are involved 
with excessive airway denudation due to  thinning of epithelium and hyperplasia of 
goblet cells.  
The basement membrane is thickened by collagen deposition, infiltration of  CD4+          
lymphocytes,mast cells,eosinophils and neutrophils. The submucous muscle is                 
contracted.  Submucous  glands are hyperplastic secreting mucus. Reduction in small 
airway  diameter increases airway resistance as a result expiratory flow rates and flow 
volumes are decreased. The lumen of bronchi are filled with mucus,eosinophils,            
edema fluid, Charcot- leyden crystals, inssipitated mucus plugs and Crushmann              
spirals.  
 
SIMILARITIES BETWEEN UPPER AND LOWER AIRWAY113  
Pseudostratified ciliated columnar epithelium 
Lamina propria 
Triangular basal cells 
Goblet cells 
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MECHANSIMS RELATED TO SINUSITIS AND ASTHMA114 
The mechansims which link sinusitis and asthma are as follows 
EOSINOPHIL 
Eosinophil plays a major role in mediating injury to epithelium caused in bronchial  
asthma and sinusitis. The deposition of eosinophils in sinus mucosa correlates with             
cytokine production  such as interleukin-2(IL-2) and granulocyte macrophage colony 
stimulating factor (GM-CSF)  resulting in extracellular deposition of major basic             
protein and sinus mucosa damage. The same mechanism has been described in case of 
bronchial asthma also and demonstrated by histopathological specimens. All these 
suggest    eosinophil acts as an effector cell in chronic inflammatory disease of  sinus 
and lower airway. 
INFLAMMATORY MEDIATORS  
Sinusitis  acts as an aggravator for bronchial asthma by stimulating irritant               
receptors   leading to bronchospasm by the inflammatory mediators. The induction of 
Th2-type cells by the inhaled antigen or allergen causes release of interleukins IL-4 
and IL-5.  
       Activation of eosinophil  and recruitment of mast cells are taken care by these                     
interleukins. This forms the base for IgE mediated hypersensitivity in acute and late                
response. The   sensitized   mast cells cause mediator release and penetration of the 
antigen to the  submucosal  mast cells. Bronchoconstriction occurs by central and               
local  reflexes   explained below in  the neural pathways.  This is acute phase reaction. 
The late phase  reaction is triggered by the release of cytokines from mast cells and 
other  inflammatory cells.   
  
45 
 
The leukotrienes C4,D4, and E4 are potent mediators that cause prolonged constriction 
of the bronchi , increased vascular permeability and mucus production. The smooth 
muscles of airway is constricted by acetylcholine released from the interpulmonary 
motor nerves by stimulation of muscarinic receptors. 
Local  mediators of inflammation like histamine, prostaglandin D2 , platelet activating 
factor  may be aspirated to lungs resulting in seeding of lower airways with nasal           
mucopurulent secretions.  
 
NEURAL PATHWAYS 
The neuroanatomic reflex pathway which connects nose and lung is as follows 
Receptors in nose , pharynx, paranasal sinuses form afferent fibres of trigeminal nerve 
which relay in reticular formation in brain stem. 
The dorsal stem nuclei of vagus in reticular formation  gives rise to parasympathetic           
vagal efferent  cholinergic fibres which reach bronchi smooth muscle.  
All the above said mechanisms putforth  the theory of unified airway or single airway 
linking  upper airway and lower airway and relationship between pathogenesis of             
sinusitis and bronchial asthma. 
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MATERIALS   AND  METHODS 
INCLUSION CRITERIA  : 
1. History of bronchial asthma . 
2.  History of persistence of symptoms of asthma for  atleast six weeks inspite      
           of COPD management. 
 3.18-55 year age group 
 4.Asthmatic patients with history suggestive of chronic   sinusitis 
 
EXCLUSION CRITERIA :  
The patients with 
 1. H/o chronic smoking 
2. Systemic illness 
3. Pregnancy 
4. Lactating mothers 
5. H/o allergy to antibiotics 
PLACE OF STUDY   : Thanjavur  medical college 
PERIOD OF STUDY   :   July 2015 to  September 2016  
 
EVALUATION OF PATIENTS 
Patients with asthma usually present with symptoms of  shortness of breath (dyspnea), 
wheeze ,cough and chest tightness as suggested by  National  heart,lung and blood              
institute guidelines for diagnosis and management of asthma125 . 
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The patients were graded according to National  Asthma  Education and  Prevention  
Programme126  
DISEASE  
SEVERITY 
SYMPTOMS NOCTURNAL 
OCCURRENCE 
LUNG FUNCTION 
Mild intermittent Symptoms  less than 
two times a week 
Asymptomatic and 
normal PEF between 
exacebrations 
< 2times per 
month 
PEF  >80% of  predicted 
PEF variability     <20% 
Mild persistent Symptoms >2times a 
week but less than 1 
time a day  
Exacebrations may 
affect activity 
 
>2times a month PEF >80%of predicted 
PEF variability 20-30% 
Moderate persis-
tent 
Daily symptoms 
Daily use of  short 
acting β2 agonist in-
haler 
Exacebrations>2times 
a week and it affects 
activity 
>1time a week PEF >60% but <80% 
predicted 
PEF variability >30% 
Severe persistent Continual symptoms 
Limited physical     
activity 
Frequent                
exacebrations 
Frequent  PEF <60%    
predicted 
 
PEAK EXPIRATORY FLOW RATE127  
Measurement of peak expiratory flow is of value in assessment and follow-up of               
patients with asthma. Wright’s  peak flow meter has been used here .It is the maximal 
flow by  expiration in maximal force after a full inspiration. There is a diurnal               
variation in peak expiratory flow rate , the lowest values occurring in morning and 
highest during  4 to 6 pm.  
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Each measurement should be highest value of  three consecutive maneuvers before 
usage of bronchodilators. Peak expiratory flow rate  provides objective measurements  
to follow and  monitor therapy.   
 
The values are  usually divided into three zones 
ZONE PEFR VALUE GRADE OF ASTHMA 
GREEN  >80% expected PEFR  Mild  
YELLOW 50- 80% expected PEFR Moderate  
RED < 50% expected PEFR Severe  
 
 FORMULA FOR PEFR CALCULATION128  
 MALES 
AGE 7-15Yrs 16-40Yrs >40yrs 
FORMULA (5×Ht in cms)-420 (2.74×Ht in cms)+53.4 567-(2.24×age) 
Normal  value 80-450 l/min 400-650 l/min 300-500 l/min 
 
FEMALES 
AGE 7-15Yrs 16-40Yrs >40Yrs 
FORMULA (5×Ht in cms)-430 (4.65×Ht in cms)-360 438-(2.24×Age) 
NORMAL VALUE 70-400 l/mins 250-400 l/min 200-400 l/min 
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Diagnostic criteria of  chronic rhinosinusitis 
1. Persistence  of symptom for 12 weeks or more with findings of sinusitis on                 
examination  and or radiological evaluation. 
2. One of these signs in association with the symptoms 
a) Discoloured drainage, nasal polyp or polypoidal mucosa on examination 
with  anterior rhinoscopy or endoscopic examination. 
b) Edema or erythema of middle meatus in nasal endoscopic examination.            
c) Generalized edema or erythema, granulation tissue( if middle meatus or                    
    ethmoid bulla not involved imaging is required. 
 d)  CT scan of paranasal sinuses demonstrating mucosal thickening, air-  fluid 
level or  bony changes. 
e)  Plain X-ray of paranasal sinuses showing mucosal thickening more than 
5mm  or complete opacity. 
 
For diagnosis  presence of two major factor or one major and two minor factors or 
mere presence middle meatus purulence is enough. 
When the above criteria are met, patients are subjected for diagnostic nasal                         
examination using 0º and 30º Hopkins rod endoscope under local anesthesia. The             
endoscopic findings  were graded using  Lund Kennedy endoscopic grading system 
and scored as  
Polyp – 0 – absent,1- within the middle meatus, 2- beyond the middle meatus 
Discharge – 0- absent,1- thin clear , 2- thick purulent 
Edema -0- absent , 1-mild, 2- severe 
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In post operative endoscopic examination scoring of scarring and crusting was also            
considered 
Scarring -0-absent, 1-mild, 2-severe 
Crusting -0-absent, 1-mild, 2- severe 
The radiological imaging scoring by Lund MacKay system with each side sinuses and 
osteomeatal complexes considered separately and scored. The status of maxillary,           
anterior ethmoids, posterior ethmoids, frontal and sphenoid sinuses as  
0- No abnormality 
1- Partial opacity 
2- Complete opacification 
Osteomeatal complex 
0- No obstruction 
2-obstructed 
Drug consumption in treatment of asthma was also considered in the study giving an           
arbitrary score of one point each for prednisolone tablet, salbutamol tablet,                       
theophylline tablet and inhaler puff usage. Two points for nebulization and injection. 
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RESULTS  AND OBSERVATION 
 
50 asthmatic patients who presented with sinusitis were screened using Task 
force criteria and subjected to nasal endoscope and plain  X-ray of paranasal                 
sinuses(Water’s view) and CT scan of paranasal sinuses  if necessary. Out of the 50 
patients , 8 patients were selected as control group  by random selection method. The 
remaining 42 patients were treated  medically  with  antibiotics, antihistamines and  
nasal decongestant drops for a period of  three weeks.  
Before starting medical  management peak expiratory flow rate was recorded in 
all of them. 25 patients responded well with medical treatment  and 17 patients were 
refractory to medical management.  In those patients who were treated medically peak 
expiratory flow rate was recorded six weeks after stopping medical management . The 
17 refractory patients to medical management were subjected to functional endoscopic 
sinus surgery  and   measurement of peak expiratory flow rate  done after six weeks 
postoperatively .  
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AGE DISTRIBUTION CHART 
Patients were selected between 18 to 55yrs of age and the distribution as follows 
AGE TOTAL FEMALE MALE 
15-20 3 1 2 
21-25 12 3 9 
26-30 8 2 6 
31-35 11 5 6 
36-40 3 3 0 
41-45 5 2 3 
46-50 2 2 0 
51-55 6 6 0 
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MEDICALLY MANAGED PATIENTS 
AGE /SEX BEFORE MEDICATION (cells/cu.mm) 
AFTER MEDICATION 
(cells/cu.mm) 
19/F 783 385 
21/F 672 376 
24/F 527 330 
28/F 439 234 
31/F 432 231 
31/F 863 308 
33/F 544 264 
36/F 512 236 
37/F 843 323 
39/F 636 307 
44/F 480 237 
48/F 428 236 
52/F 819 205 
53/F 567 342 
55/F 921 325 
55/F 537 208 
20/M 440 236 
21/M 754 247 
22/M 611 344 
24/M 933 311 
25/M 504 219 
26/M 657 264 
29/M 864 262 
29/M 859 307 
31/M 536 276 
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SURGICALLY  MANAGED  PATIENTS 
AGE/SEX BEFORE SURGERY (cells/cu.mm) 
AFTER SURGERY 
(cells/cu.mm) 
18/M 566 321 
22/M 819 335 
25/M 1023 347 
25/M 413 282 
28/M 532 302 
30/M 510 340 
33/M 497 276 
35/M 382 180 
41/M 372 198 
41/M 526 334 
24/F 527 330 
30/F 908 327 
35/F 618 332 
42/F 873 310 
46/F 456 204 
51/F 523 318 
53/F 921 325 
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CONTROL GROUP 
AGE/SEX START OF STUDY (cells/cu.mm) 
AFTER SIX WEEKS 
(cells/cu.mm) 
21/M 633 602 
25/M 791 785 
29/M 1033 1034 
33/M 434 420 
33/M 590 586 
35/M 948 950 
44/M 604 604 
31/F 473 475 
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DRUG CONSUMPTION CHART 
The changes in consumption of usage of drug was noted before the start of study and 
end of six weeks after starting treatment. 
 
AT START OF STUDY 
Drug Medically  
managed patients 
Surgically 
 managed patients Control group 
Prednisolone(1) 25 17 8 
Salbutamol(1) 8 7 2 
Theophylline (1) 12 6 5 
Inhaler / Rotacap(1) 4 4 1 
Nebulization (2) 1 2 1 
 
In the patients who were managed by medications,  all 25 of them  were on                
steroids,  8 of them on salbutamol, 12 on theophylline, 4 on usage of inhaler or 
rotacap and one of them required nebulization along with other drugs usage. 
In surgically managed patients  all 17 of them were on steroid , 7 on salbutamol, 
6 on theophylline, 4 on inhaler and 2  requiring nebulization along with other                     
medications. 
In control group the whole sample of 8 require  steroids , 2 on salbutamol, 5 on             
theophylline and one inhaler and nebulization. 
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IN MEDICALLY MANAGED PATIENT 
The following chart shows the changes in PEFR before and after medication 
AGE/SEX HEIGHT IN Cms 
EXPECTED 
VALUE 
(l/min) 
BEFORE 
MEDICATION 
(l/min) 
AFTER  
MEDICATION 
(l/min) 
19/F 138 282 186(66%) 225(80%) 
21/F 142 300 252(84%) 282(94%) 
24/F 135 268 206(77%) 241(90%) 
28/F 150 338 250(74%) 314(93%) 
31/F 155 360 298(83%) 313(87%) 
31/F 160 384 215(56%) 326(85%) 
33/F 148 328 255(78%) 295(90%) 
36/F 152 347 277(80%) 326(94%) 
37/F 154 356 252(71%) 320(90%) 
39/F 168 421 286(68%) 362(86%) 
44/F 157 340 292(86%) 312(92%) 
48/F 153 331 251(76%) 307(93%) 
52/F 144 322 280(87%) 302(94%) 
53/F 153 320 220(69%) 272(85%) 
55/F 162 315 204(65%) 277(88%) 
55/F 147 315 264(84%) 283(90%) 
20/M 147 457 301(66%) 374(82%) 
21/M 158 487 354(73%) 438(90%) 
22/M 136 426 332(78%) 391(92%) 
24/M 152 470 385(82%) 413(88%) 
25/M 160 491 387(79%) 427(87%) 
26/M 166 508 320(63%) 447(88%) 
29/M 170 519 446(84%) 482(93%) 
29/M 153 473 335(71%) 425(90%) 
31/M 148 459 312(68%) 399(87%) 
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PEAK EXPIRATORY FLOW IN SURGICALLY MANAGED PATIENTS 
The following chart shows changes in PEFR pre and postoperative 
AGE/SEX HEIGHT IN Cms 
EXPECTED 
VALUE(l/min) 
PREOPERATIVE 
(l/min) 
POSTOPERATIVE 
(l/min) 
18/M 152 470 376(80%) 423(90%) 
22/M 160 491 392(80%) 451(92%) 
25/M 148 478 239(50%) 320(67%) 
25/M 155 459 275(60%) 358(78%) 
28/M 163 501 350(70%) 420(84%) 
30/M 168 514 334(65%) 442(86%) 
33/M 174 530 275(52%) 397(75%) 
35/M 161 495 331(67%) 396(80%) 
41/M 156 475 256(54%) 327(69%) 
41/M 164 475 399(84%) 446(94%) 
24/F 132 254 152(60%) 190(75%) 
30/F 140 291 226(78%) 241(83%) 
35/F 150 338 216(64%) 270(80%) 
42/F 154 348 295(85%) 323(93%) 
46/F 147 335 244(73%) 288(86%) 
51/F 156 324 197(61%) 301(93%) 
55/F 147 320 197(57%) 284(89%) 
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PEAK EXPIRATORY FLOW RATE IN CONTROL GROUP 
 
AGE HEIGHT IN Cms 
EXPECTED 
(l/min) 
AT START 
OF STUDY 
AFTER SIX 
WEEKS 
21/M 163 500 330(66%) 330(66%) 
25/M 158 486 398(82%) 388(80%) 
29/M 154 475 351(74%) 351(74%) 
33/M 170 519 290(56%) 290(56%) 
33/M 156 481 365(76%) 365(76%) 
35/M 148 459 307(67%) 298(65%) 
44/M 151 468 397(85%) 374(80%) 
31/F 152 346 214(62%) 214(62%) 
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STASTICAL ANALYSIS OF DATA  
MEDICALLY TREATED PATIENTS  
The sample is 25. Applying paired sample ‘t' test 
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Pair1  
Expected 
value 386.96 81.01 
.880 .000<.05 
significant 97.0 38.84 12.48 2 
.000<.05 
significant 
Before 
medication 289.96 66.48 
Pair2 
Expected 
value 386.96 81.01 
.976 .000<.05 
significant 44.1 18.61 11.8 24 
.000<.05 
significant After 
medication 342.80 72.847 
Pair3 
Before 
medication 289.96 66.48 
.917 .000<.05 
significant 52.84 29.01 9.105 24 
.000<.05 
significant 
After 
medication 342.80 72.847 
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SURGICALLY MANAGED PATIENTS 
The sample size is 17 and applying paired  sample ‘t’ test 
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Pair 1 
Expected 
value 417.53 91.52 
.752 .001<.05 
significant 138.76 60.67 9.43 16 
.000<.05 
significant Pre-
operative 278.76 75.01 
Pair2 
Expected 
value 417.53 91.52 
.885 .000<.05 
significant 71.82 42.67 6.94 16 
.000<.05 
significant Post-
operative 345.71 78.59 
Pair3 
Pre-
operative 
 
278.76 75.01  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
.000<.05 
significant 
 Post-
operative 345.71 78.59  .925 
.000<.05 
significant 66.94 30.009 9.19 16 
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CONTROL GROUP 
The sample size is 8 and applying  paired sample ‘t’ test 
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Pair1 
 
Expected 
value 
466.75 
 
52.262 
 
.631 
 
 
.093>0.05 
Not 
significant 
 
135.25 
 
 
49.491 
 
7.73 
 
 
7 
 
 
.000<.05 
significant 
 
 At time 
of study 331.50 61.349 
Pair2  
Expected 
value 
466.75 
 
 
52.262 
 
.669 
 
.070>.05 
 
Not sig-
nificant 
 
140.50 
 
 
44.779 
 
 
8.875 
 
 
7 
 
 
 
.000<.05 
significant 
 After  6 
weeks 326.25 57.238 
 
Pair3 
At 
time 
of 
study 
331.50 61.349 .992 
 
.000<.05 
significant 
 
5.25 
 
8.362 
 
1.776 
 
7 
 
.119>.05 
Not  
significant 
After 
6 
weeks 
326.25 57.238 
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Applying  Chi-square test for  
 
GENDER SAMPLE  - is significant 
Gender Medically treated 
Surgically 
treated Control Total 
Statistical 
inference 
MALE 9(36%) 10(58.8%) 7(87.5%) 26(52%) 
 
 
X2=6.920 
Df=2 
P value 
.031<.05 
significant 
FEMALE 16(64%) 7(41.2%) 1(12.5%) 24(48%)   
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DISCUSSION 
Upper and lower respiratory  tracts respond to stimuli in similar manner and 
provocation of upper airway produce  changes in lower airway has been demonstrated.  
The pulmonary component of asthma when treated alone produces only short term  
relief and response in patient health condition but, when combined treatment of upper 
airway also ensures entire disease management. 
In this study which comprise of  patient from 18 to 55years age group,6% of 
sample size by 15-20 age group, 24% of them were in 21-25 age group followed by 
16% of sample size by 26-30 age group,31-35 age group comprising 22% of the             
sample size.36- 40 yr age group account for 6% of sample size, 10% by 41-45 age 
group, 4% by 46-50 yrs sample and 12% by 51-55 yr age group of the sample size. 
There was significant influence of allergic component and environmental factors            
visualized by 52% of study population was male and rest 48% by females , supported 
by Chi-square test results. 
Monitoring of eosinophil count showed good improvement in the counts                   
following the treatment of sinusitis in asthmatic patients. In the medically managed 
patients  the eosinophil mean  which was 646 at the start of study  improved to 280  
after six weeks of treatment .In the surgically treated patients also significant change 
in mean value prior to surgery was 615 and after surgery was 297. Whereas  in the 
control group there was no change in mean value of eosinophil count.  The overall 
shift of baseline mean value of the   eosinophil count from 642 to 350 following 
treatment of sinusitis  was  noted. This suggest control of pathogenesis of asthma in 
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concomitant treatment of sinusitis documented by the  decrease in eosinophil count 
which is the major effector cell in release of cytokines in both acute and late phase  
reaction of asthma triggering the mast cells and causing bronchoconstriction .  The 
stimulation of airways significantly reduce following treatment of sinusitis.  
The drug monitoring in patients  showed reduction in usage of steroids,               
salbutamol, theophylline , inhaler  and nebulization. At the start of study 100% of the 
sample size was on steroid therapy accounting to 50%  of the sample in medically 
managed category, 34% in surgically treated patients and 16% of the sample size in 
control group. 
In the 25 patients  medically managed patients, 100% of them needed steroid 
medication for asthma which reduced to 64% after addressing treatment for sinusitis. 
32% of the patients were on salbutamol which fell down to 16% after treatment for 
sinusitis. 48% of the patients  on theophylline reduced to 20% and the usage of inhaler 
in 16% of patients did not require them after treatment for sinusitis. 
In the 17 surgically treated patients,  100% of the patients in this category were 
on steroid usage reduced to 45% after surgery for sinusitis. In case of salbutamol             
usage 35% of the patients before surgery trickled down to 20% after surgery. 30% of 
the patients on  theophylline documented a reduction to 10% after surgery. The 20% 
of the patients  requiring  inhaler subsided to 10% after surgery.  
In the control group there was no change in the requirement of medications     
neither at  the start of study nor at the end of six weeks starting the study. 
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 The overall  effect of sinus treatment in asthma showed reduction in usage of 
steroids in 64% of patient, 57% reduction in β2 agonists and almost nil usage of               
nebulization. 
PEFR was used as tool in assessing clinical improvement in patient’s health and 
day to day activites, also to measure efficacy of treatment prior to start of study and 
after start of study in tackling sinusitis in asthmatic patients. 
In medically treated patients the PEFR mean baseline value prior to treatment 
was  289.96 l/min substantial increase was observed at the end of six weeks after   
starting medications to 342.80 l/min.  
In surgically managed patients, the PEFR value at the start of trial was 278.76 
l/min grossly increased to 345.71 l/min postoperatively. 
 Whereas in the control group there was no change in the PEFR value.  All these 
have been statistically analysed and found to have ‘p’ value which was significant in 
medically managed and surgically treated group unlike control group where ‘p’ value 
was  insignificant by paired sample ‘t’ test.  
Similar observations has been studied by Slavin129 in 1982 where  he found that                
corticosteroid dependency reduced following simultaneous treatment of sinusitis in      
asthmatic patients. 
In the study conducted in Government medical college of Aurangabad130 in year 
1986 evaluated the PEFR value changes in asthmatic patients following treatment of  
sinusitis with  antibiotic, antihistamines and nasal decongestants. The baseline PEFR 
mean value 197.2 l/min increased to 250.4 l/min after sinusitis treatment. There was 
60% reduction in asthmatic drug medication following sinusitis treatment. 
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Royal national throat,nose and ear hospital in London131 conducted a study in the 
year 2005 found out improvement in  asthma symptoms and reduction usage of             
asthmatic medications by addressing problem of sinusitis with medications and         
functional  endoscopic sinus surgery.  
The effectiveness of medical therapy is due to combined administration of              
antibiotics, antihistamines and nasal decongestants which control the inflammatory  
response in upper airway by decreasing the microbiological load, reducing number of 
leukocytes and downregulating cytokines and inflammatory mediators. 
Surgically managed patients also showed improvement in both subjective and 
objective lower airway parameters. 
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CONCLUSION 
Sinusitis and asthma may co-exist and impact the effect of pathogenesis of the 
disease on one another. 
Identification of asthmatic patients with sinusitis is an important task which may 
be carried out by proper history, examination , necessary investigation and                 
imaging. CT scan of  paranasal sinuses is the key diagnostic tool in hand with                
endoscopic examination to detect isolated sphenoid and ethmoid sinusitis, anatomical 
abnormalities, osteomeatal complex obstruction by playing an upper hand in                   
diagnosing sinusitis than conventional X-rays . 
The role of sinusitis in pathogenesis of asthma is accomplished by neuro                 
anatomical pathway that connects paranasal sinuses to lungs. Production of                 
inflammatory mediators, eosinophil, mast cells in sinusitis resulting in subsequent        
recruitment of the same into lungs suggest the common effector pathway in                  
pathogenesis of sinusitis and asthma. 
Proper medical and surgical management of sinusitis in asthmatic patients results 
in   improvement in lung function, allergic response, PEFR value increase as been             
observed in this study. Decreased exacerbation of asthmatic attacks, decreased              
consumption of drugs, minimal usage of inhaler and emergency hospitalization thus 
improves the quality of life style in asthmatic patients along with decrease in overall 
cost of  health care. It has also been documented in this study medical therapy is               
superior to surgical management in course of the study. 
  
  
78 
 
                                                BIBLIOGRAPHY 
1. Role of sinus and disease in asthma – Claus  Bachert, Joke Patau-current                 
       opinion in  allergy  and clinical immunology 2006,6:29-36  
2. Surgical anatomy – Skandalaki;2004;6:table 6.1 
3. Disease of the sinuses – Kennedy, Bolger and Zeinreich, 2001;3: 35-47 
4. Surgical anatomy – Skandalaki;2004;2: table 2.1 
5. Disease of the sinuses – Kennedy, Bolger and Zeinreich; 2001;3b: 35-47 
6. Disease of the sinuses -  Kennedy, Bolger and Zeinreich ;2001,3b: 35-47 
7. Medical embryology –Langman; 2007; 15: 363-403 
8. Medical embryology –Langman ;2007;15:363-403 
9. Medical embryology –Langman ; 2007;15:363-403 
10. Medical embryology –Langman ;2007:15:363-403 
11. Medical embryology –Langman, 2007; 15:363-403 
12. Medical embryology –Langman; 2007; 15:363-403 
13. Medical embryology –Langman; 2007; 15:363-403 
14. Medical embryology –Langman ;2007; 15:363-403 
15. Medical embryology –Langman ;2007; 15:363-403 
16. Medical embryology –Langman ;2007; 15:363-403 
17. Anatomical principles of endoscopic sinus surgery a step by step approach-                     
Renuka Bradoo,2005; 1:3-13 
18. Anatomical principles of endoscopic sinus surgery a step by step approach-          
Renuka Bradoo, 2005;1:3-13 
  
79 
 
19. Anatomical principles of endoscopic sinus surgery a step by step approach-           
Renuka  Bradoo, 2005;1:3-13 
20. Anatomical principles of endoscopic sinus surgery a step by step approach-            
Renuka Bradoo,2005;1:3-13 
21. Disease of the sinuses -  Kennedy, Bolger and Zeinreich,2001 ;1:1-13 
22.  Disease of the sinuses -  Kennedy, Bolger and Zeinreich,2001; 1:1-13 
23. Disease of the sinuses -  Kennedy, Bolger and Zeinreich;2001; 1:1-13 
24. Disease of the sinuses -  Kennedy, Bolger and Zeinreich;2001;  1:1-13 
25. Disease of the sinuses -  Kennedy, Bolger and Zeinreich, 2001;1:1-13 
26.  Disease of the sinuses -  Kennedy, Bolger and Zeinreich ;2001:1:1-13 
27. Disease of the sinuses -  Kennedy, Bolger and Zeinreich, 2001;1:1-13 
28. Disease of the sinuses -  Kennedy, Bolger and Zeinreich,2001; 1:1-13 
29. Disease of the sinuses -  Kennedy, Bolger and Zeinreich,2001; 1:1-13 
30. Diseases of the sinuses-Kennedy,Bolger and Zeinreich ;2001;1:1-13 
31. Disease of the sinuses -  Kennedy, Bolger and Zeinreich;2001; 1:1-13 
32. Disease of the sinuses -  Kennedy, Bolger and Zeinreich, 2001;1:1-13 
33. Sinusitis from microbiology to management- Izthak Brook,2006; 5:95-109 
34. Sinusitis from microbiology to management- Izthak Brook, 2006;5:95-109 
35. Sinusitis from microbiology to management- Izthak Brook,2006; 5:95-109 
 
36. Disease of the sinuses -  Kennedy, Bolger and Zeinreich, 2001;1:1-13 
 
37. Disease of the sinuses -  Kennedy, Bolger and Zeinreich, ,2001; 1:1-13 
38. Disease of the sinuses -  Kennedy, Bolger and Zeinreich, , 2001;1:1-13 
  
80 
 
39. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior skull 
base- Reda Kamel ; 2003;1:6-34  
40. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior skull 
base- Reda Kamel , 2003;1:6-34 
41. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior skull 
base- Reda Kamel ; 2003;1:6-34 
42. Disease of the sinuses -  Kennedy, Bolger and Zeinreich,2001; 1:1-13 
43. Disease of the sinuses -  Kennedy, Bolger and Zeinreich,2001; 1:1-13 
44. Disease of the sinuses -  Kennedy, Bolger and Zeinreich; 2001;1:1-13 
45. Disease of the sinuses -  Kennedy, Bolger and Zeinreich; 2001;1:1-13 
46. Functional endoscopic sinus surgery-Messerklinger technique-Heinz                        
Stammberger; 1991;3:49-89 
47. Diseases of sinuses- A comprehensive textbook of  diagnosis and treatment –
Christopher.C.Chang- 2014;1:3-45 
48. Diseases of sinuses- A comprehensive textbook of  diagnosis and treatment –  
Christopher.C.Chang, 2014;1:3-45 
49.  Diseases of sinuses- A comprehensive textbook of  diagnosis and treatment –  
Christopher.C.Chang, 2014;1:3-45 
50. Diseases of sinuses- A comprehensive textbook of  diagnosis and treatment –  
Christopher .C. Chang; 2014;1:3-45 
51. Diseases of sinuses- A comprehensive textbook of  diagnosis and treatment –        
Christopher .C. Chang;2014; 1:3-45 
  
81 
 
52. Diseases of sinuses- A comprehensive textbook of  diagnosis and treatment –           
Christopher .C. Chang,2014; 1:3-45 
53. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior skull   
      base- Reda Kamel ;2003;1:6-43 
54. Diseases of sinuses- A comprehensive textbook of  diagnosis and treatment –  
 
Christopher .C. Chang, 2014;1:3-45 
 
55. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior skull  
          base- Reda Kamel ,2003;1:6-43 
56. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior skull  
base- Reda Kamel ,2003;1:6-43 
57. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior 
skull base- Reda Kamel ;2003;1:6-43 
58. Diseases of sinuses- A comprehensive textbook of  diagnosis and treatment –  
          Christopher .C. Chang;2014;1:3-45 
59.     Diseases of sinuses- A comprehensive textbook of  diagnosis and treatment –  
 
    Christopher .C. Chang; 2014;1:3-45 
 
60. Disease of the sinuses -  Kennedy, Bolger and Zeinreich;2001; 1:1-13 
61. Disease of the sinuses -  Kennedy, Bolger and Zeinreich; 2001;1:1-13 
62. Endoscopic sinus surgery –Levine & May;1993;1:1-29 
63. Disease of the sinuses -  Kennedy, Bolger and Zeinreich;2001, 2: 13-29 
64.  Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior 
skull  base- Reda Kamel ; 2003;1:6-43 
 
  
82 
 
65. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior 
skull base- Reda Kamel ;2003;1:6-43 
66. Disease of the sinuses -  Kennedy, Bolger and Zeinreich;2001; 1:1-13 
67. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior 
skull  base- Reda Kamel ;2003;1:6-43 
68. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior 
skull  base- Reda Kamel ; 2003; 1.1: 6-34 
69. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior 
skull  base- Reda Kamel ;2003;1:6-43 
70. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior 
skull base- Reda Kamel ;2003;1:6-43 
71. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior 
skull   base- Reda Kamel ;2003;1:6-43 
72. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior 
skull   base- Reda Kamel ;2003;1:6-43 
73. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior 
skull  base- Reda Kamel;2003;1:6-43  
74. Disease of the sinuses -  Kennedy, Bolger and Zeinreich;2001;1:1-13 
75. Endoscopic anatomy of lateral nasal wall, osteomeatal complex and anterior 
skull base- Reda Kamel ;2003;1:6-43 
76. Anatomical principles of endoscopic sinus surgery a step by step approach-  
 Renuka Bradoo;2005;3:31-59 1. 
 
  
83 
 
77.       Anatomical principles of endoscopic sinus surgery a step by step approach-  
            Renuka Bradoo;2005;3:31-59 
78. Diseases of sinuses- A comprehensive textbook of  diagnosis and treatment –   
           Christopher .C. Chang;2014;2:45-57 
79. Diseases of sinuses- A comprehensive textbook of  diagnosis and treatment –  
           Christopher .C. Chang;2014;2:45-57 
80.     Medical embryology –Langman:2007;12:275-285 
 
81. Medical embryology –Langman:2007;12:275-285 
82. Medical embryology –Langman;2007;12:275-285 
83. Medical embryology –Langman;2007;12:275-285 
84. Grant’s atlas of anatomy;2009;7.59 
85. Grant’s atlas of anatomy;2009;7.59 
86. Grant’s atlas of anatomy;2009;7.59 
87. Snell’s clinical anatomy by regions;8th edition ; 3:78-144 
88. Snell’s clinical anatomy by regions;8th edition; 3:78-144 
89. Textbook of histology – Inderbi Singh 
90. Snell’s anatomy by regions;8th edition; 3:78-144 
91. Sinusitis from microbiology to management- Itzhak Brook;2006;4:55-95 
92. Otolaryngology basic science & review –Thomas R. Van De Water Hinrich  
            Staecker;2006;39:472-485 
93. Otolaryngology basic science & review –Thomas R. Van De Water Hinrich  
           Staecker;2006;39:472-485 
 
  
84 
 
94. Functional endoscopic sinus surgery- Messerklinger technique- Stammberger- 
           1991;2:17-48 
95. Diseases of sinuses- A comprehensive textbook of  diagnosis and  treatment  
           Christopher .C. Chang,2014;2:45-57 
96. Otolaryngology basic science & review –Thomas R. Van De Water, Hinrich     
            Staecker;2006;39:472-485 
97. Functional endoscopic sinus surgery- Messerklinger technique- Stammberger-     
     1991;2:17-48 
98.      Functional endoscopic sinus surgery- Messerklinger technique- Stammberger-   
 
      1991;2:17-48 
 
99.      Functional endoscopic sinus surgery- Messerklinger technique- Stammberger-   
          1991;2:17-48 
100. Functional endoscopic sinus surgery- Messerklinger technique- Stammberger-   
        1991;2:17-48 
 
101. Functional endoscopic sinus surgery- Messerklinger technique- Stammberger-   
          1991;2:17-48 
 
102. Otolaryngology basic science & review –Thomas R. Van De Water, Hinrich 
Staecker;2006;39:472-485 
103. Nasal reflexes,JN Baraniuk11L06 
104. Scott & Brown 7th edition;2008;106:1355-1372 
105. Otolaryngology basic science & review –Thomas R. Van De Water  Hinrich  
          Staecker;2006;5:59-71 
106. Washington manual of allergy, asthma & immunology;2013;4:46-63 
 
  
85 
 
107. Otolaryngology basic science & review –Thomas R. Van De Water Hinrich  
              Staecker;2006;5:59-71 
108. Otolaryngology basic science & review –Thomas R. Van De Water Hinrich  
             Staecker;2006;5:59-71 
109. Otolaryngology basic science & review –Thomas R. Van De Water Hinrich  
               Staecker;2006;59-71 
110. Paediatric nasal and sinus disorder Tania Sih, Peter.A.R.Clement;2006;2:15-29 
111. Sinusitis from microbiology to management- Izthak Brook;2006;6:109-135 
112. Current review of asthma- Michael.E.Kaliner;2003;3:24-34 
113. Diseases of sinuses- A comprehensive textbook of  diagnosis and  treatment –  
            Christopher .C. Chang;2014;11:173-195 
114. Current review of asthma-Michael.E.Kaliner;2003;7:61-69 
115. Journal of allergy and clinical immunology;September1992,volume90, issue3  
      part2, pages 534-537 
116. Official journal of American academy of otolaryngology-head and neck  
             surgery;[1994,110(6);494-500] 
117. 1996 Annals of asthma, allergy & immunology –Kennedy 
118. Epidemiological evidence of occurrence of rhinitis, sinusitis and asthma,  
            volume54,issue s57,November 1999;7-13 
119. Journal of allergy  & clinical immunology,April2002:606-608 
120. CHEST journal-American college of chest physiciaans,August1,2006 
121. Current opinion in pulmonary medicine,2009 january,15(1) 19-24 
122. American review of respiratory disease,vol147,No.2,1993; pg314-320 
  
86 
 
123. GA 2LEN survey of Europe- asthma in adults and its association with chronic  
             Rhinosinusitis;volume67,issue 1,January 2012,91-98 
124. American journal of rhinology & allergy;volume26, number 3,  
            May/June 187-     190(4) 
125. Current review of asthma – Michael.E.Kalliner;2003;13:118-123 
126. Current review of asthma –Michael .E.Kaliner;2003;13:118-123 
127. Current review of asthma-Michael.E.Kaliner;2003;13:118-123 
128. Evaluating the suitability of paediatric equation for lung function in Indian  
          children- Sumathi et Al;Indian Paediatrics;volume 43, August 17 2006 
129. Slavin study of sinusitis and asthma interrelation  1982;Ann Allergy;49:76-80 
130. Journal of Indian academy of clinical medicine- 2002;3(3):258-65 
131. Treatment of chronic rhinosinusitis and its effects on asthma- S.Ragab- Royal  
           national throat nose and ear hospital of London- 2005-European respiratory  
           journal 2006;28:68-74 
 
 
  
  
  
87 
 
 APPENDIX -1 
SCREENING   PROFORMA 
Name :                      Age:              Sex:       Occupation: 
Chief complaints: 
History : 
Nasal discharge 
Nasal obstruction 
Headache  
Facial pain 
Postnasal discharge 
Halitosis 
Ear pain/ear fullness 
Dental pain  
Abnormalities in smell 
h/o epistaxis 
H/o sneezing 
H/o allergy 
Fever &cough 
Change in voice 
H/o breathlessness 
H/o asthma 
Frequency  of asthmatic attacks, diurnal and nocturnal variation 
Asthmatic drugs used 
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Precipitating and relieving factors 
Family h/o asthma, COPD, TB, DM,HT 
Personal H/o : smoking, alcohol intake, snuff usage,betel nut usage, previous nasal 
surgeries 
 
GENERAL PHYSICAL EXAMINATION 
Built: 
Nourishment : 
Pallor/Icterus/lymphadenopathy/Clubbing/Cyanosis 
Vital signs 
Pulse rate:                   Respiratory rate :            Temperature: 
Blood pressure: 
 
SYSTEMIC EXAMINATION 
Cardiovascular system: 
Respiratory system 
Central nervous system 
Abdomen examination 
 
LOCAL EXAMINATION  
NOSE 
External appearance 
Anterior rhinoscopy : 
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Vestibule  
Columella 
Floor of nasal cavity 
Septum 
Turbinate – inferior and middle  
Meatus – inferior and middle  
Post nasal examination 
Cold spatula test  
Paranasal  sinus tenderness elicitation- Frontal,Maxillary,Ethmoid sinus 
Ear and Throat examination 
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                                        APPENDIX -2 
DIAGNOSTIC NASAL ENDOSCOPIC FORM 
 RIGHT LEFT 
FIRST PASS 
SEPTUM   
NASAL MUCOSA   
INFERIOR 
TURBINATE   
INFERIOR MEATUS   
CHOANA   
EUSTACHIAN 
TUBE   
FOSSA OF ROSENMUL-
LER   
SECOND PASS 
MIDDLE TURBINATE   
MIDDLE MEATUS   
UNCINATE   
BULLA ETHMOIDALIS   
ACCESSORY OSTIUM   
THIRD PASS 
SPHENOETHMOIDAL 
RECESS   
SUPERIOR TURBINATE   
SUPERIOR MEATUS   
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                                              APPENDIX – 3 
CONSENT FORM 
I __________________________________________ hereby give consent to 
participate in the study conducted by Department of  Otorhinolaryngology, Thanjavur 
medical college hospital and to use my personal clinical data and result of                 
investigation for the purpose of analysis and to study the nature of disease. I also give 
consent for further        investigations. 
 
 
Place : 
Date :       Signature of participant 
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MASTER CHART 
MEDICALLY MANAGED PATIENTS 
S.NO NAME AGE/SEX HEIGHT IN Cms 
SINUSITIS EVAL-
UATION 
ASTHMA EVALUATION 
BEFORE MEDICATION 
AFTER 
MEDICATION 
DNE CT GRADE PEFR GRADE PEFR  
1 Sumathi 19/F 138 M,E M,E Mo 186 Mi 225 
2 Saranya 21/F 142 E E Mi 252 Mi 282 
3 Vimala 24/F 135 M,E M,E Mo 206 Mi 241 
4 Irudaya mary 28/F 150 M,E M,E,S Mo 250 Mi 314 
5 Sugashini 31/F 155 M,E M,E Mi 298 Mi 313 
6 Kalpana 31/F 160 M,E M,E Se 215 Mi 326 
7 Malarvizhi 33/F 148 M M Mo 255 Mi 295 
8 Jeyakodi 36/F 152 M,E M,E Mi 277 Mi 326 
9 Kala 37/F 154 M,E M,E Mo 252 Mi 320 
10 Sasikala banu 39/F 168 M,E,S M,E,S Mo 286 Mi 362 
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S.NO NAME AGE/SEX HEIGHT IN Cms 
SINUSITIS EVALUATION 
ASTHMA-
EVALUATION  
BEFORE MEDICATION 
AFTER MEDICATION 
 
 
DNE CT GRADE  PEFR l/min 
PEFR 
l/min GRADE 
11 Sulochana 44/F 157 M,E M,E Mi  292 312 Mi 
12 Banumathi 48/F 153 M,E,S M,E,S Mo 251 307 Mi 
13 Shanthi 52/F 144 M,E M,E Mi 280 302 Mi 
14 Lakshmi 53/F 153 M,E M,E Mo  220 272 Mi 
15 Yogeswari 55/F 162 M,E M,E Mo  204 277 Mi 
16 Manimegalai  55/F 147 M,E,S M,E,S Mi  264 283 Mi 
17 20/M Shankar 147 M,E M,E Mo  301 374 Mi 
18 Senthil kumar 21/M 158 M,E M,E Mo 354 438 Mi 
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S.NO NAME AGE/SEX 
HEIGHT 
IN Cms 
SINUSITIS 
EVALUATION 
ASTHMA EVALUA-
TION 
BEFORE MEDICATION 
AFTER MEDICATION 
   DNE CT PEFR GRADE PEFR GRADE 
19 Suresh         22/M 136 M,E M,E 332 Mo 391 Mi 
20  Murugesan 24/M 152 M,E,S M,E,S 385 Mi 413 Mi 
21 Balakrishnan 25/M 160 M,E M,E 387 Mo 427 Mi 
22 Nihamathulla 26/M 166 M M 320 Mo 447 Mi 
23 Thiruvengadam 29/M  170 M,E M,E 446 Mi 482 Mi 
24  Kannan 29/M 153 M,E M,E 335 Mo 425 Mi 
25 Ramesh 31/M 148 M,E M,E 312 Mo 399 Mi 
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S.NO NAME AGE/SEX 
HEIGH
T IN 
Cms 
SINUSITIS 
EVALUA-
TION 
 
ASTHMA EVALUATION 
PRE- OPERATIVELY 
POST OPERA-
TIVELY 
   DNE  CT PEFR GRADE PEFR GRADE 
1. 18/M Veeramani 152 M, CB,  M,CB 376 Mi 423 Mi 
2 Chandrasekar 22/M 160 B/L SP  B/LSP 392 Mi 451 Mi 
3 Raja 25/M 155 M,E,S  M,E,S 239 Se 320 Mo 
4 Baskar25/M 148 M,E  M,E 275 Se 358 Mo 
5 Mahesan 28/M 148 M,E, CB  M,E,CB 350 Mo 420 Mi 
6 Arokya dhass 30/M 163 M,S,E  M,S,E 334 Mo 442 Mi 
7 Durai pandiyan 33/M 168 M,E  M,E 275 Se 397 Mo 
8 Palaniswamy 35/M 174 M,E,  M,E 331 Mo 396 Mi 
9 Sachidanandham 41/M 161 M,E,PM  M,E,PM 256 Se 327 MO 
10 Adaikalaraj  41/M 156 M,E  M,E 399 Mi 446 Mi  
11 Muthulakshmi24/F 132 M,E  M,E 152 Se 190 Mo  
12 Malathi 30/F 140 M,E  M,E 226 Mo 241 Mi 
13 Jeyanthi 35/F 150 B/L SP  B/L SP 216 Mo 270 Mi 
14 Jothi 42/F 154 M,E  M,E 295 Mi 323 Mi 
15 Vetrikodi 46/F 147 M,E,S  M,E,S 244 Mo 288 Mi 
16 Yogam 51/F 156 M,E  M,E 197 Mo 301 Mi 
17 Pattammal 53/F 147 M,E  M,E 182 Se 284 Mi 
 
SURGICALLY MANAGED PATIENTS 
 
  
96 
 
 
 
CONTROL GROUP 
S.NO NAME AGE/SEX HEIGHT IN Cms 
SINUSITIS 
EVALUATION 
ASTHMA 
EVALUATION 
AT START OF 
STUDY 
AFTER SIX WEEKS 
  
 DNE CT PEFR GRADE PEFR GRADE 
1 Srikanth 21/M 163 M,E M,E 330 Mo 330 Mo 
2 Tamilarasan 25/M 158 M,E M,E 398 Mi 388 Mi 
3 Singaravelan 29/M 154 M,E M,E 351 Mo 351 Mo 
4 Manikandan 33/M 170 M,E M,E 290 Se 290 Se 
5 Subramani 33/M 156 M M 365 Mo 365 Mo 
6 Eswaran 35/M 148 M,E M,E 307 Mo 298 Mo 
7 Mariappan 44/M 151 M,E M,E 397 Mi 374 Mi 
8 Vetrikodi 31/F 
 
152 
 
M,E 
 
M,E 
 
214 
 
Mo 
 
214 
 
Mo 
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KEY TO MASTER CHART 
M- Maxillary sinusitis 
E- Ethmoid sinusitis 
S- Sphenoid sinusitis 
CB- Concha Bullosa 
SP- Sinonasal polyposis 
Mi- Mild 
Mo- Moderate 
Se-severe 
 
